You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Patent: 10,022,451


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,022,451
Title:Encapsulated agents and methods of making and using thereof
Abstract: The subject matter disclosed herein relates to compositions that contain a protein cage and a therapeutic agent, such as a photosensitizer. The protein cage is a protein that binds metal ion. The composition can further contain a cell recognition moiety. The methods disclosed are for permeabilizing the endothelial lining of a cancerous tissue or for treating a cancerous tissue to cause therapeutic injury resulting in the reduction of at least one of the surface area, the depth, and the amount of the tissue affected by the cancerous condition, in a subject.
Inventor(s): Xie; Jin (Athens, GA), Zhen; Zipeng (Athens, GA), Tang; Wei (Athens, GA)
Assignee: University of Georgia Research Foundation, Inc. (Athens, GA)
Application Number:14/709,090
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,022,451

Introduction

When analyzing a patent, particularly one like United States Patent 10,022,451, it is crucial to delve into the specifics of the claims, the patent landscape, and the broader implications of the patent. This analysis will cover the key aspects of patent claims, inventorship, the patent application process, and the competitive landscape.

Understanding Patent Claims

Patent claims are the heart of any patent application, defining the scope of the invention and what is protected by the patent. For a patent like 10,022,451, the claims must meet the criteria of being novel, non-obvious, and useful[4].

Conception and Reduction to Practice

The determination of inventorship, which is critical in patent law, focuses almost exclusively on the conception step. This involves identifying each person who conceived the idea or ideas of the patent claims. Conception is defined as the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention, sufficient for one with ordinary skill in the field to reduce it to practice without extensive research or experimentation[1].

Claim Scope and Meaning

To analyze the claims of 10,022,451, one must first determine the scope and meaning of each claim. This involves understanding what the invention claimed is and who conceived each of the claims. The claims must include every feature of the subject matter claimed in the patent[1].

Inventorship Determination

Inventorship is a critical aspect of patent law, and errors in this area can have significant consequences.

True and Only Inventors

Only those who conceived the subject matter of at least one claim of the patent are considered inventors. This can include one person or multiple persons who collaborate to produce the invention through aggregate efforts. However, individuals whose only contribution is reducing the invention to practice by exercising ordinary skill in the art are not considered inventors[1].

Correcting Errors in Inventorship

While errors in inventorship can be corrected, it is crucial to perform an accurate determination before filing the patent application. Corrections are easier to make while the patent application is pending rather than after it has issued. Deceptive intent in naming inventors can render the patent unenforceable[1].

The Patent Application Process

The process of obtaining a patent involves several key steps and interactions with the patent office.

File Wrappers and Prosecution History

The file wrapper, or prosecution history, of a patent application contains detailed discussions between the patent applicant and the patent office examiner. This includes arguments made regarding the novelty, non-obviousness, and usefulness of the claims in light of prior art. Analyzing the file wrapper can provide valuable insights into the patent's legal status and the competitive landscape[4].

Office Actions and Rejections

During the patent application process, the examiner may issue office actions, including rejections, based on prior art. The applicant can respond by narrowing or limiting the scope of the submitted claims to overcome these rejections. This iterative process continues until the patent is either allowed or abandoned[4].

Patent Trial and Appeal Board (PTAB)

The PTAB, established by the Leahy-Smith America Invents Act (AIA), plays a significant role in challenging the validity of patents.

Inter Partes Review (IPR) and Post-Grant Review (PGR)

PTAB conducts IPR and PGR proceedings, which allow anyone to challenge the validity of patents. These processes are often faster and less expensive than judicial proceedings and require a lower burden of proof to invalidate patents. This can be particularly relevant for entities facing patent infringement claims[3].

Competitive Intelligence and Patent Landscape

Understanding the broader patent landscape is essential for competitive intelligence.

Analyzing Prior Art and File Wrappers

Reviewing prior art and the file wrappers of related patents can provide insights into the technological advancements and legal strategies employed by competitors. This information is crucial for making informed decisions about investments and innovation strategies[4].

Government-Interest Patent Disclosures

In some cases, patents may involve government-interest disclosures, which can indicate funding or involvement by government agencies. However, such disclosures are relatively rare, even among top-selling drugs, highlighting the predominantly private nature of most patent developments[2].

Case Study: United States Patent 10,022,451

Claim Analysis

To analyze the claims of 10,022,451, one would need to review the patent specification and claims to understand the scope and meaning of each claim. This involves identifying the key features of the invention and determining who conceived these features.

Inventorship

Verifying the inventors listed on the patent is crucial. This involves ensuring that only those who conceived the subject matter of the claims are listed and that there was no deceptive intent in naming the inventors.

Prosecution History

Reviewing the file wrapper of 10,022,451 would provide insights into the interactions between the applicant and the examiner, including any office actions, rejections, and responses. This can help in understanding the legal status and the competitive positioning of the patent.

Competitive Landscape

Analyzing the patent landscape involves looking at related patents, prior art, and any government-interest disclosures. This helps in understanding the technological context and competitive environment in which the patent operates.

Key Takeaways

  • Accurate Inventorship: Ensuring the correct inventors are listed is critical to the validity and enforceability of a patent.
  • Claim Scope: Understanding the scope and meaning of each claim is essential for determining the protection offered by the patent.
  • Prosecution History: The file wrapper provides valuable insights into the patent's legal status and competitive landscape.
  • PTAB and IPR: The PTAB and IPR processes can significantly impact the validity of patents and should be considered in strategic planning.
  • Competitive Intelligence: Analyzing prior art and related patents is crucial for making informed decisions about innovation and investment.

FAQs

Q: What is the significance of the conception step in determining inventorship? A: The conception step is crucial as it involves the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention. Only those who conceived the idea are considered inventors[1].

Q: How can errors in inventorship be corrected? A: Errors in inventorship can be corrected, but it is easier to do so while the patent application is pending rather than after it has issued. Deceptive intent in naming inventors can render the patent unenforceable[1].

Q: What is the role of the Patent Trial and Appeal Board (PTAB)? A: PTAB conducts IPR and PGR proceedings to challenge the validity of patents, providing a faster and less expensive alternative to judicial proceedings[3].

Q: Why is analyzing the file wrapper important? A: The file wrapper contains detailed discussions between the applicant and the examiner, providing insights into the patent's legal status and competitive landscape[4].

Q: How common are government-interest patent disclosures? A: Government-interest patent disclosures are relatively rare, even among top-selling drugs, indicating that most patent developments are privately funded[2].

Sources

  1. Determining Inventorship for US Patent Applications - Oregon State University[1]
  2. Federal government-interest patent disclosures for recent top-selling small-molecule drugs - PubMed[2]
  3. The Patent Trial and Appeal Board and Inter Partes Review - Congressional Research Service[3]
  4. Patent file wrappers as a tool for competitive intelligence - IP Checkups[4]

More… ↓

⤷  Try for Free

Details for Patent 10,022,451

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Genentech, Inc. RITUXAN rituximab Injection 103705 November 26, 1997 10,022,451 2039-02-26
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 September 25, 1998 10,022,451 2039-02-26
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 February 10, 2017 10,022,451 2039-02-26
Genzyme Corporation CAMPATH alemtuzumab Injection 103948 May 07, 2001 10,022,451 2039-02-26
Genzyme Corporation LEMTRADA alemtuzumab Injection 103948 November 14, 2014 10,022,451 2039-02-26
Genzyme Corporation CAMPATH alemtuzumab Injection 103948 October 12, 2004 10,022,451 2039-02-26
Eli Lilly And Company ERBITUX cetuximab Injection 125084 February 12, 2004 10,022,451 2039-02-26
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.